PACYX
Price
$11.66
Change
+$0.03 (+0.26%)
Updated
Jun 2 closing price
Net Assets
837.51M
SAUPX
Price
$13.04
Change
+$0.03 (+0.23%)
Updated
Jun 2 closing price
Net Assets
2.18B
Interact to see
Advertisement

PACYX vs SAUPX

Header iconPACYX vs SAUPX Comparison
Open Charts PACYX vs SAUPXBanner chart's image
PACYX vs SAUPX Comparison Chart in %
View a ticker or compare two or three
VS
PACYX vs. SAUPX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PACYX is a Buy and SAUPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SAUPX has more cash in the bank: 2.18B vs. PACYX (838M). PACYX pays higher dividends than SAUPX: PACYX (3.25) vs SAUPX (2.85). PACYX was incepted earlier than SAUPX: PACYX (32 years) vs SAUPX (30 years). SAUPX (1.00) is less costly to investors than PACYX (0.71). PACYX is a more actively managed with annual turnover of: 243.00 vs. SAUPX (23.90). PACYX has a lower initial minimum investment than SAUPX: PACYX (0) vs SAUPX (1000). PACYX annual gain was more profitable for investors over the last year : 11.18 vs. SAUPX (9.71). PACYX return over 5 years is better than : 12.36 vs. SAUPX (10.36).
PACYXSAUPXPACYX / SAUPX
Total Expense Ratio0.711.0071%
Annual Report Gross Expense Ratio0.711.0071%
Fund Existence32 years30 years-
Gain YTD3.8223.310115%
Front LoadN/A4%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets838M2.18B38%
Annual Yield % from dividends3.252.85114%
Returns for 1 year11.189.71115%
Returns for 3 years31.4426.11120%
Returns for 5 years12.3610.36119%
Returns for 10 years41.6339.34106%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CARR66.421.31
+2.01%
Carrier Global Corp
PASG5.950.10
+1.71%
Passage Bio Inc
EE32.740.12
+0.37%
Excelerate Energy
OLLI79.24-1.62
-2.00%
Ollie's Bargain Outlet Holdings
KROS10.52-0.38
-3.49%
Keros Therapeutics